Norres, a portfolio company of Triton Smaller Mid-Cap Fund I, acquired the Baggerman Group. The parties have agreed not to disclose the purchase price. The Baggerman Group, headquartered in Roermond, Netherlands, is a specialist manufacturer of industrial hoses, couplings and related parts. The company has subsidiaries in Italy, Switzerland, Hungary and Romania. A […]
The city of Sierre, the association of the municipalities of the District of Sierre and TechnoArk acquired a majority stake in the Techno-Pôle of Sierre. Python acted as counsel to the buyers. Python team
Maus Frères and Coop-Group cooperative announced the sale of all shares of Jumbo-Markt, a Swiss do-it-yourself store operator, for an undisclosed consideration. Following merger control clearance by the Swiss Competition Commission the transaction has
Combioxin, a clinical phase biotechnology company based in Epalinges, Switzerland, has signed a worldwide commercial license agreement with Eagle Pharmaceuticals, a fully integrated pharmaceutical company based in Woodcliff Lake, NY, USA. Under the terms of
La Mobilière, TX Group, Ringier and General Atlantic form a joint venture to create a digital marketplace group. The CEO of the joint venture will be Gilles Despas, currently CEO of the Scout24 Switzerland
VectivBio Holding, clinical-stage biopharmaceutical company specialising in novel transformational treatments for severe rare conditions announced the acquisition of Comet Therapeutics, a biotechnology company that has been developing drugs to address previously untreatable inherited metabolic diseases.
Dekra, the German vehicle inspection company, announced the acquisition of a minority stake in Spearhead, a Swiss company specializing in data analytics for automotive claims and vehicle lifecycle management. Homburger acted as legal counsel to
The Renaissance Investment Foundation has become a long-term majority shareholder in the capital of bb trading werbeartikel, the distributor of promotional items and customer gifts in Switzerland. CMS Switzerland provided comprehensive legal and tax
Thommen-Furler – the parent company of a group specializing in the fields of distribution of chemicals, specialties and lubricants, environmental technology and the disposal and recycling of industrial and hazardous waste with a turnover of approx,
Atlas Antibodies, a global developer of advanced reagents for biomedical research based in Sweden, has agreed to acquire Evitria Group from its shareholders. The transaction closed on August 5, 2021. Vischer advised the sellers on this
